Optimizing Prograf® Therapy in Renal Transplant Patients

Completed · Phase 4

Conditions studied: Renal Transplantation

In brief

A study to determine the optimal dose and blood level of Prograf® in long-term maintenance of kidney transplant patients.

Key facts

Study ID

NCT00297765

Run by

Astellas Pharma Inc

People needed

323

Starts

2003-01-01

Expected to finish

2006-03-01

Last updated by the study team

2008-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient was 18 years of age at the time of transplant.
• Patient is at least 6 months post-transplant.

You may not qualify if…

• Patient is the recipient of a solid organ transplant other than the kidney.
• Patient is a known carrier of any of the HIV viruses.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Los Angeles, California, United States
• Study site — Palo Alto, California, United States
• Study site — San Diego, California, United States
• Study site — San Francisco, California, United States
• Study site — Denver, Colorado, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Atlanta, Georgia, United States
• Study site — Augusta, Georgia, United States
• Study site — Honolulu, Hawaii, United States
• Study site — Peoria, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Portland, Maine, United States
• Study site — Boston, Massachusetts, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — Omaha, Nebraska, United States
• Study site — Livingston, New Jersey, United States
• Study site — West Orange, New Jersey, United States
• Study site — Buffalo, New York, United States
• Study site — Long Island City, New York, United States
• Study site — Mineola, New York, United States
• Study site — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.